首页> 美国卫生研究院文献>Pulmonary Circulation >Incidence and risk factors of chronic thromboembolic pulmonaryhypertension following venous thromboembolism a population-based cohort studyin England
【2h】

Incidence and risk factors of chronic thromboembolic pulmonaryhypertension following venous thromboembolism a population-based cohort studyin England

机译:慢性血栓栓塞性肺的发病率和危险因素一项基于人群的队列研究:静脉血栓栓塞后高血压在英国

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Chronic thromboembolic pulmonary hypertension (CTEPH) is a complication of unresolved organised pulmonary emboli/thrombi obstructing the major pulmonary arteries. The aim of this study was to estimate the incidence and risk factors of CTEPH in a cohort with first venous thromboembolism (VTE). This was a population-based cohort study of patients with first VTE and no active cancer in England between 2001 and 2012. CTEPH was assessed using a rigorous case-ascertainment algorithm. Risk factors for CTEPH were studied using a nested case-control approach by matching CTEPH cases to VTE patients without CTEPH. Adjusted odds ratios (OR) of comorbidities were estimated from conditional logistic regression. During 81,413 person-years of follow-up among 23,329 patients with first VTE (mean follow-up 3.5 years; maximum 11.0 years) 283 patients were diagnosed with CTEPH (incidence rate 3.5 per 1000 person-years); cumulative incidence was 1.3% and 3.3% at 2 and 10 years after pulmonary embolism, and 0.3% and 1.3% following deep vein thrombosis (DVT), respectively. Risk factors for CTEPH included age over 70, OR 2.04 (95% CI 1.23 to 3.38), female gender, 1.44 (1.06 to 1.94), pulmonary embolism at first VTE, 3.11 (2.23 to 4.35), subsequent pulmonary embolism and DVT, 3.17 (2.02 to 4.96) and 2.46(1.34 to 4.51) respectively, chronic obstructive pulmonary disease 3.17 (2.13 to4.73), heart failure 2.52 (1.76 to 3.63) and atrial fibrillation, 2.42 (1.71 to3.42). CTEPH develops most commonly after pulmonary embolism and less frequentlyafter DVT. Awareness of risk factors may increase referrals to specialisedcentres for confirmation of CTEPH and initiation of specific treatment.
机译:慢性血栓栓塞性肺动脉高压(CTEPH)是未解决的有组织的肺栓塞/血栓阻塞主要肺动脉的并发症。这项研究的目的是评估患有第一静脉血栓栓塞症(VTE)的队列中CTEPH的发生率和危险因素。这是一项基于人群的队列研究,研究对象是2001年至2012年期间英格兰首例VTE且无活动性癌症的患者。CTEPH使用严格的病例确定算法进行评估。使用嵌套病例对照方法,通过将CTEPH病例与没有CTEPH的VTE患者匹配,研究了CTEPH的危险因素。从条件对数回归估计合并症的调整后的优势比(OR)。在23,329例首次VTE患者中,有81,413人-年的随访(平均随访3.5年;最大11.0年),有283例患者被诊断为CTEPH(发生率3.5 / 1000人-年)。肺栓塞后2年和10年的累积发生率分别为1.3%和3.3%,深静脉血栓形成(DVT)后的累积发生率分别为0.3%和1.3%。 CTEPH的危险因素包括70岁以上,OR 2.04(95%CI 1.23至3.38),女性,1.44(1.06至1.94),初次VTE时发生肺栓塞,3.11(2.23至4.35),随后发生的肺栓塞和DVT,3.17 (2.02至4.96)和2.46(1.34至4.51),慢性阻塞性肺疾病3.17(2.13至4.73),心力衰竭2.52(1.76至3.63)和心房纤颤2.42(1.71至3.42)。 CTEPH在肺栓塞后最常见,而较不常见DVT之后。对危险因素的意识可能会增加转介给专业人士的风险确认CTEPH和启动特定治疗中心。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号